RECAP • $AMZN: Developing smart glasses for delivery drivers to aid navigation. • $ARMK: Q4 EPS $0.54 vs. $0.53 est., new $500M buyback, dividend up 11%, FY25 guidance increased. • $BLMN: Downgraded to Market Perform by Raymond James. • $BKNG: Announces organizational changes and layoffs. • $TSLA: Shares up 7% premarket, reached $1T market cap post-Trump win. • $ENPH: Cutting 17% of workforce, expects $17-20M in restructuring costs. • $NOV: Downgraded to Neutral by Citigroup, target price cut to $18. • $SMR: Filed for up to $200M share offering. • $Russia: Potential merger of major oil companies into one entity. • $FTX: Sued Binance & Zhao for $1.8B, also suing Scaramucci. • $GEHC & $RDNT: Collaborating on AI in imaging. • $INSP: $75M share repurchase program. • $TEVA: Seeking to reverse patent decision. • $TSM: Ordered to stop exporting advanced AI chips to China. • $SPNS: Reduced FY24 revenue forecast, Q3 underperformed. • $SONY: Q2 profit up 69%, game biz profits doubled, PS5 sales at 3.8M. • $PINS: Upgraded to Outperform by Wedbush.

#Downgrades - Nov 11, 2024 • $AGL: JMP Securities Downgrades to Market Perform from Market Outperform • $ALTM: Scotiabank Downgrades to Sector Perform from Sector Outperform - PT $5.85 • $ARDX: H.C. Wainwright Downgrades to Neutral from Buy - PT $5.50 • $ATMU: Wells Fargo Downgrades to Equal Weight from Overweight - PT $45 (from $42) • $BLMN: Raymond James Downgrades to Market Perform from Outperform • $CBT: JPMorgan Downgrades to Underweight from Neutral - PT $105 • $CE: BMO Capital Downgrades to Underperform from Market Perform - PT $76 (from $138) • $CE: UBS Downgrades to Neutral from Buy - PT $97 (from $161) • $GCMG: TD Cowen Downgrades to Hold from Buy - PT $15.50 • $IMCR: Mizuho Downgrades to Neutral from Outperform - PT $38 (from $72) • $MRK: Daiwa Securities Downgrades to Neutral from Outperform • $NOV: Citi Downgrades to Neutral from Buy - PT $18 (from $21) • $NRDY: JPMorgan Downgrades to Underweight from Neutral • $NVR: Seaport Global Securities Downgrades to Neutral from Buy • $PRA: Piper Sandler Downgrades to Neutral from Overweight - PT $18 • $RVTY: Nephron Downgrades to Sell from Sell - PT $105 • $SMAR: Guggenheim Downgrades to Neutral from Buy • $TDW: Raymond James Downgrades to Outperform from Strong Buy - PT $102 (from $131) • $TEM: Stifel Downgrades to Hold from Buy - PT $65 (from $45) • $VALE: UBS Downgrades to Neutral from Buy - PT $11.50 (from $14) • $WHF: Oppenheimer Downgrades to Perform from Outperform - PT $12 (from $14) • $XERS: Piper Sandler Downgrades to Neutral from Overweight - PT $3